1 / 4

Female Infertility, Menopause, and Contraceptive Drugs Marke

Menopause, also termed as climacteric, refers to cessation of menstruation. It usually occurs in females aged between 45 and 55 years. Female infertility refers to a condition of infertility in females. Various causes for female infertility are polycystic ovary syndrome (PCOS), hypothalamic dysfunction, premature ovarian insufficiency, and hyperprolactinemia.

veronicasavio
Télécharger la présentation

Female Infertility, Menopause, and Contraceptive Drugs Marke

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. FemaleInfertility,Menopause,andContraceptiveDrugsMarket:GlobalIndustryFemaleInfertility,Menopause,andContraceptiveDrugsMarket:GlobalIndustry AnalysisandForecast2014-2020 PersistenceMarketResearch FemaleInfertility,Menopause,and ContraceptiveDrugsMarket:GlobalIndustry AnalysisandForecast2014-2020 1 PersistenceMarketResearch

  2. FemaleInfertility,Menopause,andContraceptiveDrugsMarket:GlobalIndustryFemaleInfertility,Menopause,andContraceptiveDrugsMarket:GlobalIndustry AnalysisandForecast2014-2020 PersistenceMarketResearchReleasedNewMarketReporton“FemaleInfertility, Menopause,andContraceptiveDrugsMarket:GlobalIndustryAnalysisandForecast 2014-2020”. Menopause,alsotermedasclimacteric,referstocessationofmenstruation.Itusuallyoccursinfemales agedbetween45and55years.Femaleinfertilityreferstoaconditionofinfertilityinfemales.Various causesforfemaleinfertilityarepolycysticovarysyndrome(PCOS),hypothalamicdysfunction,premature ovarianinsufficiency,andhyperprolactinemia.Contraceptivesaredrugsanddevicesthatareusedto preventpregnancyandsexuallytransmittedinfections.Contraceptivedrugsarefurtherclassifiedas contraceptivepills,topicalcontraceptives,andcontraceptiveinjectables.Thefemaleinfertility, menopause,andcontraceptivedrugsmarketisgrowingatasignificantrateduetoincreasingdisorders relatedtofertilityandmenopauseandrisingawarenessaboutdifferentmenopause,femaleinfertilityand contraceptivedrugs.Inaddition,governmentinitiativesforimprovingfemalehealtharedrivingthemarket forfemaleinfertility,menopause,andcontraceptivedrugs. BuyFullReport:http://www.persistencemarketresearch.com/market-research/female-infertility- menopause-contraceptive-drugs-market.asp NorthAmericadominatestheglobalmarketforfemaleinfertility,menopauseandcontraceptivedrugsdue totheincreasingprevalenceofdisordersrelatedtomenopauseandfemaleinfertilityintheregion.In addition,highusageofcontraceptivepillsintheregionduetothehighefficiencyprovidedbythedrugsis drivingtheoverallmarketforcontraceptives.Asia,followedbyEurope,isexpectedtoexperiencehigh growthrateinthenextfewyearsinthefemaleinfertility,menopause,andcontraceptivedrugsmarket. ChinaandIndiaareexpectedtobethefastestgrowingfemaleinfertility,menopause,andcontraceptive drugsmarketsinAsia.Someofthekeydrivingforcesforthefemaleinfertility,menopauseand contraceptivedrugsmarketinemergingcountriesarelargepoolofpatientsandrisinggovernment initiativesbyfundingandstrictlaws. Increasingawarenessaboutdifferentdisordersinfemalefertility,menopause,andcomplicationsin femalehealthbynotusingbirthcontrolmeasuresiscontributingtothegrowthofthemarketforfemale infertility,menopauseandcontraceptivedrugs.Inaddition,theincreasingprevalenceoffemalesexual disordersandimprovementinhealthcarefacilitiesandtechnologicaladvancementsinthefieldhavebeen drivingthefemaleinfertility,menopause,andcontraceptivedrugsmarket.However,thesideeffects 2 PersistenceMarketResearch

  3. FemaleInfertility,Menopause,andContraceptiveDrugsMarket:GlobalIndustryFemaleInfertility,Menopause,andContraceptiveDrugsMarket:GlobalIndustry AnalysisandForecast2014-2020 associatedwiththeintakeofcontraceptivedrugsandloweradoptionratesfordrugsassociatedwith treatmentoffemaleinfertilityandmenopausehavebeenrestrainingthemarket. GrowingpopulationsanddevelopingeconomiesincountriessuchasIndiaandChinaareexpectedto offergoodopportunitiesfortheglobalfemaleinfertility,menopause,andcontraceptivedrugsmarket.The arrivalonthemarketofsomenewproductswithbetterefficiencyisexpectedtooffergoodopportunityfor theglobalfemaleinfertility,menopause,andcontraceptivedrugsmarket.Thegrowingnumberofmergers andacquisitions,newproductlaunches,andincreasingnumberofcollaborationsandpartnershipsare someofthelatesttrendsthatobservedintheglobalfemaleinfertility,menopauseandcontraceptive drugsmarket.Thesideeffectsassociatedwithintakeoffemaleinfertility,menopause,andcontraceptive drugsareachallengeforthemarket.Someofthemajorcompaniesdealinginglobalmenopause,fertility andcontraceptivedrugsmarketincludeAventisSA,Bristol-MyersSquibbCompany,Johnson&Johnson, andMerck&Company,Inc.Othersignificantplayersintheglobalmenopause,fertility,andcontraceptive drugsmarketincludeNovartisInternationalAG,BayersAG,Pharmacia&Upjohn,Inc.,Organon,Inc., BerlexLaboratories,Parke-Davis,G.D.Searle&Company,TAPHoldingsInc.,TheAres-SeronoGroup, andAmericanHomeProductsCorporation. RequestFullTOC:http://www.persistencemarketresearch.com/toc/4280 Keypointscoveredinthereport:- 1. Reportsegmentsthemarketonthebasisoftypes,application,products,technology,etc (asapplicable) Thereportcoversgeographicsegmentation NorthAmerica Europe Asia RoW Thereportprovidesthemarketsizeandforecastforthedifferentsegmentsand geographiesfortheperiodof2010to2020 Thereportprovidescompanyprofilesofsomeoftheleadingcompaniesoperatinginthemarket Thereportalsoprovidesportersfiveforcesanalysisofthemarket. 2.     3. 4. 5. Browsethefull“AllUpcomingPersistenceMarket's”reportat http://www.persistencemarketresearch.com/forthcoming-reports.asp AboutUs: 3 PersistenceMarketResearch

  4. FemaleInfertility,Menopause,andContraceptiveDrugsMarket:GlobalIndustryFemaleInfertility,Menopause,andContraceptiveDrugsMarket:GlobalIndustry AnalysisandForecast2014-2020 PersistenceMarketResearchisaglobalmarketresearchfirmspecializing-syndicated research,customresearch,andconsultingservices AtPersistenceMarketResearch(PMR),weareinthebusinessofacceleratingyourbusiness. Asafull-servicemarketresearchfirm,westandcommittedtobringingmoreaccuracyandspeedtoyourbusinessdecisions.Fromready-to-purchasemarketresearchreportstocustomizedglobalresearchsolutions,ourengagementmodelsarehighlyflexiblewithoutcompromisingonourdeep-seatedresearchvalues.Brieflystated,ourmissionistogiveyouaccesstoforecastsandtrendsanalysesthatputyouonthepathtoprofitability. PMR’sServicesGoBeyondGleaningData: MostenterprisesbelievethatITanddatabasesareenoughtomakeanaccuratedecision.Whilewedonotdisputethat,considerthis:Howlongdoesittaketomakeanaccurateandstrategicmillion-dollardecision?Westrivetodeliverbothevenwithdemandingdeadlines. FacilitatingRapidandInformedBusinessDecisions PMRwasfoundedwithonegoalinmind:toofferenterprisesatangiblebusinessadvantagebycarefullybalancingtraditionalandmodern-dayresearchmethodologies. ContactUs: AddieThomes 305Broadway, 7thFloor, NewYorkCity,NY10007,UnitedStates. Phone:+1-646-568-7751 USA/CanadaTollFreeNumber. 1-800-961-0353 E-mail:Sales@persistencemarketresearch.com Web:http://www.persistencemarketresearch.com/ 4 PersistenceMarketResearch

More Related